Skip to search formSkip to main contentSkip to account menu

ziyuglycoside II

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide. Phytochemicals are important candidates for… 
2018
2018
Ziyuglycoside I (ZGS1) is a promising drug candidate for the treatment of leucopenia. Currently, information on ZGS1 and its in… 
2017
2017
Ziyuglycoside II, a major bioactive compound of Sanguisorba officinalis L., displays anticancer potential against several human… 
2017
2017
Radix Sanguisorbae, the root of Sanguisorba officinalis L. is used as traditional Chinese medicine. In recent decades, it has… 
2015
2015
Type 2 diabetes is a metabolic disorder caused by abnormal carbohydrate metabolism, and closely associated with abnormal lipid… 
2013
2013
  • A. Zhu, H. Zhou, T. Shan
  • Brazilian journal of medical and biological…
  • 2013
  • Corpus ID: 17670054
Ziyuglycoside II is an active compound of Sanguisorba officinalis L. that has anti-inflammation, antioxidation, antibiosis, and… 
2013
2013
Ziyuglycoside II is one of the major active compounds of Sanguisorba officinalis L., which has a wide range of clinical… 
Highly Cited
2008
Highly Cited
2008
In order to investigate the potential of a Sanguisorba officinalis root extract as an active ingredient for wrinkle-care…